Polyomaviruses and human diseases

Advances in Experimental Medicine and Biology

Volumn 577, Issue , 2006, Pages 1-18

  Ahsan, Nasimul ^a   Shah, Keerti V ^b  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS DNA;

BLOOD; CEREBROSPINAL FLUID; GENETICS; HUMAN; PATHOGENICITY; PATHOPHYSIOLOGY; POLYOMA VIRUS; REVIEW; URINE; VIRUS INFECTION;

ANTIVIRAL AGENTS; DNA, VIRAL; HUMANS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS;

EID: 33745593517     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-32957-9_1     Document Type: Review

References (185)

1. Padgett BL, Walker DL, Zu Rhein GM et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; i:1257-1260.
2. Gardner SD, Field AM, Coleman DV et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; i:1253-1257.
3. Sweet BH, Hillemean MR. The vacuolating virus, SV 40. Proc Soc Exp Biol Med 1960; 105:420-427.
4. Mortimer EA, Lepow ML, Gold E et al. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. N Engl J Med 1981; 305:1517-1518.
5. Ahsan N, Shah KV. Polyomaviruses: An overview. Graft 2002; 5:S9-18.
6. Walker DL, Frisque RJ. The biology and molecular biology of JC virus. In: Salzman NP, ed. The papovaviridae, the polyomaviruses. New York: Plenum Press, 1986:1:327-377.
7. Moens U, Johansen T, Johansen JI et al. Noncoding control region of naturally occurring BK virus variants: Sequence comparison and functional analysis. Virus Genes 1995; 10:261-75.
8. Kristoffersen AK, Johnsen JI, Seternes OM et al. The human polyomavirus BK T antigen induces genes expression in human cytomegalovirus. Virus Res 1997; 52:61-71.
9. Cubitt c, Stoner G. Molecular genetics of the BK virus. Graft 2002; 5:S20-28.
10. Imagawa M, Chiu R, Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP. Cell 1987; 51:251-260.
11. Moens U, Sundsfjord A, Flaegstad T et al. BK virus early RNA transcripts in stably transformed cells: Enhanced levels induced by dibutyryl cyclic AMP, forskolin and 12-O-tetradecanoylphorbol-13-acetate treatment. J Gen Virol 1990; 71:1461-1471.
12. Knepper JE, DiMayorca G. Cloning and characterization of BK virus-related DNA sequences from normal and neoplastic human tissues. J Med Virol 1987; 21:289-299.
13. Newman JT, Frisque RJ. Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient. J Med Virol 1997; 52:243-52.
14. Loeber G, Dorries K. DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol 1988; 62:1730-5.
15. Ault GS, Stoner GL. Brain and kidney of progressive multifocal leukoencephalopathy patients contain identical rearrangements of the JC virus promoter/enhancer. J Med Virol 1994; 44:298-304.
16. Moens U, Rekvig OP. Molecular biology of BK virus and clinical and basic aspects of BK virus renal infection. In: Khalili K, Stoner GL, ed. Human polyomaviruses. Molecular and clinical perspectives. New York: Willey-Liss Inc., 2001:359-408.
17. Moens U, Seternes OM, Johansen B et al. Mechanism of transcriptional regulation of cellular genes SV40 larger T- and small t-antigens. Virus Genes 1997; 15:135-154.
18. Kornberg RD. Structure of chromatin. Annu Rev Biochem 1977; 46:931-954.
19. McGhee JD, Felsenfeld G. Nucleosome structure. Annu Rev Biochem 1980; 49:1115-1156.
20. Kornberg RD, Lorch Y. Twenty-five years of nucleosome, fundamental particle of the eukaryotic chromosome. Cell 1999; 98:285-294.
21. Andreassen K, Bredholt G, Moens U et al. T cell lines specific for polyomavirus T-antigen recognize T-virus complexed with nucleosomes: A molecular basis for anti-DNA antibody production. Eur J Immunol 1999; 29:2715-2728.
22. Liddington RC, Yan Y, Moulat J et al. Structure of seminal virus 40 at 3.8 - A resolution. Nature 1991; 554:278-294.
23. Rayment I, Baker TS, Casper DL et al. Polyoma virus capsis structure at 22.5 A resolution. Nature 1982; 295:13-31.
24. Resnick J, Shenk T. Simian virus 40 agnoprotein facilitates normal nuclear location of the major capsid polypeptide and cell-to-cell spread of virus. J Virol 1986; 60:1098-1106.
25. Endo S, Okada Y, Nishihara H et al. JC virus agnoprotein co localizes with tubulin. J Neuro Virol 2003; 9:10-14.
26. Beckmann A, Shah K. Propagation and primary isolation of JCV and BKV in urinary epithelial cell cultures. In: Sever JL, Madden DL, eds. Polyomaviruses and human neurological diseases. New York: Alan R Liss, 1983:3-14.
27. Marshall WF, Telenti A, Proper J et al. Rapid detection of polyomavirus BK by a shell vial cell culture assay. J Clin Microbiol 1990; 28:1613-1615.
28. Padgett B, Walker D. Natural history of human polyomavirus infections. In: Stevens JG, Todaro GJ, Fox CF, eds. Persistent viruses. New York: Academic Press, 1978:751-758.
29. Assouline JG, Major EO. Human fetal Schwann cells support JC virus multiplication. J Virol 1991; 65:1001-1006.
30. Major EO, Vacante D. Human fetal astrocytes in culture support the growth of the neurotropic human polyomavirus JCV. J Neuropathol Exp Neurol 1989; 48:425-436.
31. Aoki N, Mori M, Kato K et al. Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: A diagnostic tool for progressive multifocal leukoencephalopathy. Neurosci Lett 1996; 205:111-114.
32. Knowles WA, Gibson PE, Gardner SD. Serological typing scheme for BK-like isolates of human polyomavirus. J Med Virol 1989; 28:118-123.
33. Knowles WA, Gibson PE, Hand JF et al. An M-antibody capture radioimmunoassay (MACRIA) for detection of JC virus-specific IGM. J Virol Mehtods 1992; 40:95-105.
34. Marshall J, Smith AE, Cheng SH. Monoclonal antibody specific for BK virus large T antigens. Oncogene 1991; 6:1673-1676.
35. Frisque RJ, Rifkin DB, Walker DL. Transformation of primary hamster brain cells with JC virus and its DNA. J Virol 1980; 35:265-269.
36. Pater MM, Pater A, di Mayorca G et al. BK virus-transformed inbred hamster brain cells: Status of viral DNA in subclones. Mol Cell Biol 1982; 2:837-844.
37. Takemoto KK, Linke H, Miyarnura T et al. Persistent BK papovavirus infection of transformed human fetal brain cells. J Virol 1979; 29:1177-1185.
38. Thiele M, Grabowski G. Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch Virol 1990; 113:221-233.
39. Apperly JF, Rice SJ, Bishop JA et al. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation 1987; 43:108-112.
40. Arthur RR, Shah KV, Charache P et al. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158:563-569.
41. Atwood WJ. Cellular receptors for the polyomaviruses. In: Khallili K, Stoner GL, eds. Human polyomaviruses: Molecular and clinical perspectives. New York: Wiley-Liss, 2001:179-96.
42. Liu CK, Wei G, Atwood WJ. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha (2-6) linked sialic acids. J Virol 1998; 72:4643-9.
43. Breau WC, Atwood WJ, Norkin LC. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol 1992; 66:2037-2045.
44. Atwood WJ, Norkin LC. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J Virol 1989; 63:4474-7.
45. Kenney S, Natarajan V, Strike D et al. JC virus enhancer-promoter active in human brain cells. Science 1984; 226:1337-1339.
46. Corallini A, Pagnani M, Caputo A et al. Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey ras oncogene. J Gen Virol 1988; 69:2671-2679.
47. Knepper JE, di Mayorca G. Cloning and characterization of BK virus-related DNA sequences from normal and neoplastic human tissues. J Med Virol 1987; 21:289-299.
48. Monaco MC, Jensen PN, Hou J et al. Detection of JC virus DNA in human tonsil tissue: Evidence for site of initial viral infection. J Virol 1998; 72:9918-9923.
49. Weber T, Major EO. Progressive multifocal leukoencephalopathy: Molecular biology, pathogenesis, and clinical impact. Intervirology 1997; 40:98-111.
50. Sundsfjord A, Spein AR, Lucht E et al. Detection of human polyomavirus BK DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent patients. J Clin Microbiol 1994; 32:1390-1394.
51. Taguchi F, Nagaki D, Saito M et al. Transplacental transmission of BK virus in human. Jpn J Micrbiol 1975; 19:395-398.
52. Pietropaolo V, Di Taranto C, Degener AM et al. Transplacental transmission of human polyomavirus BK. J Med Virol 1998; 56:372-376.
53. Shah K, Daniel R, Madden D et al. Serological investigation of BK papovavirus infection pregnant women and their offspring. Infect Immun 1980; 30:29 (in recipients of renal allografts. J Infect Dis 1998; 158:176-181.
54. Arthur RR, DagostinS, Shah KV. Detection of BK virus and JC virus in urine and brain tissue by polymerase chain reaction. J Clin Microbiol 1989; 27:1174-1179.
55. Andrews CA, Shah KV, Daniel RW et al. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 198; 158:176-181
56. Major EO, Amemiya K, Tornatore CS et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992; 5:49-73.
57. Dorries K, Vogel E, Gunther S et al. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994; 198:59-70.
58. Tornatore C, Berger JR, Houff SA et al. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 1992; 31:454-462.
59. Holmberg C, Gribble D, Takernoto K et al. Isolation of simian virus 40 from rhesus monkeys (Macacca mulatta) with spontaneous progressive multifocal leukoencephalopathy. J Infect Dis 1977; 136:593-596.
60. Horvath CJ, Simon MA, Bergsagel DJ et al. Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. Am J Pathol 1992; 140:1431-1440.
61. Rosen S, Harmon W, Krensky A et al. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 1983; 308:1192-1196.
62. Gorder MA, Pelle PD, Henson JW et al. A new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunocompromised cynomolgus monkeys. Am J Pathol 1999; 154:1273-1284.
63. Goudsmit J, Wertheim-van Dillen P, van Strein A et al. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10:91-99.
64. Mantyjarvi R, Meumian O, Vihma L et al. Human papovavirus (B.K.), biological properties and seroepidemiology. Ann Dis Res 1973; 5:283-287.
65. Coleman D, Wolfendale M, Daniel R et al. A prospective study of human polyomavirus infection in pregnancy. J Infect Dis 1980; 142:1-8.
66. Arthur RR, Shah KV. The occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol 1989; 36:42-61.
67. Chang D, Wang M, Ou WC et al. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan. J Med Virol. 1996; 48:95-101.
68. Rekvig OP, Moens U. Polyoma BK and autoimmunity to nucleosomes. Graft 2002; 5:S36-S45.
69. Christie KE, Flaegstad T, Traavik T. Characterization of BK virus-specific antibodies in human sera by Western immunoblotting, native DNA are produced during BK virus infection, but not after immunization with noninfectious BK DNA. Scand J Immunol 1992; 36:487-95.
70. Rekvig OP, Moens U, Fredriksen K et al. Human polyomavirus BK and immunogenicity of mammalian DNA: A conceptual framework. Methods 1997; 11:44-54.
71. Sundsfjord A, Osei A, Rosenqvist H et al. BK and JC viruses in patients with systemic lupus erythematosus: Prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis 1999; 180:1-9.
72. Gheule MV, Moens U, Beniksen S et al. Autoimmunity to nucleosomes related to viral infection: A focus on hapten-carrier complex formation. J Autoimmunity 2003; 20:171-182.
73. Chang D, Tsai RT, Wang M et al. Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan. J Med Virol 1996; 48(2):204-9.
74. Tsai RT, Wang M, Ou WC et al. Incidence of JC viruria is higher than that of BK viruria in Taiwan. J Med Virol 1997; 52(3):253-7.
75. Boldorini R, Omodeo-Zorini E, Nebuloni M et al. Lytic JC virus infection in the kidneys of AIDS subjects. Mod Pathol 2003; 16(1):35-42.
76. Markowitz RB, Thompson HC, Mueller JF et al. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and uninfected subjects. J Infect Dis 1993; 167:13-20.
77. Shah KV, Daniel RW, Stricker HD et al. Investigation of human urine for genome sequences of the primate polyomaviruses simian 40, BK virus, and JC virus. J Infect Dis 1997; 176:1618-21.
78. Sundsfjord A, Flaegstad T, Flo R et al. BK and JC viruses in human immunodeficiency virus 1 infected persons: Prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169:485-90.
79. Knowles WA, Pillay D, Johnson MA et al. Prevalence of long term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 1999; 59:474-79.
80. Bratt G, Hammarin AL, Grandien M et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 1999; 18:1071-5.
81. Cubukcu-Dimopulo O, Greco A, Kumar D et al. BK virus infection in AIDS. Am J Surg Pathol 2002; 24:145-9.
82. Vallbracht A, Lohler J, Gossmann J et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 1993; 143:29-39.
83. Gluck TA, Knowles WA, Johnson MA et al. BK virus-associated haemorrhagic cystitis in an HIV-infected man. AIDS 1994; 8(3):391-2.
84. Barouch DH, Faquin WC, Chen Y et al. BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient. CUn Infect Dis 2002; 35(3):326-9.
85. Hirsch HH, Knowles W, Dickenmann M et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347(7):488-96.
86. Ramos E, Drachenberg CB, Portocarrero M et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002; 143-53.
87. Schmitz M, Brause M, Hetzel G et al. Infection with polyomavirus type BK after renal transplantation. Clin Nephrol 2003; 60(2):125-9.
88. Randhawa PS, Finkelstein S, Scantlebury V et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67:103-9.
89. Ginevri F, De Santis R, Comoli P et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003; 75(8): 1266-70.
90. Lin PL, Vats AN, Green M. BK virus infection in renal transplant recipients. Pediatr Transplant 2001; 5(6):398-405.
91. Lee JM, Park JH, Kim SK. BK polyomavirus interstitial nephritis in a renal allograft recipient. Ultrastruct Pathol 2003; 27(1):61-4.
92. Hirsch HH. Polyomavirus BK nephropathy: A (re)emerging complication in renal transplantation. Am J Transplant 2002; 2(1):25-30.
93. Randhawa P, Vats A, Shapiro R et al. BK virus: Discovery, epidemiology, and biology. Graft 2002; 5:S 19-S27.
94. Nickleit V, Steiger J, Mihatsch M. BK virus infection after kidney transplantation. Graft 2002; 5:S46-S57.
95. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med 2000; 342(18):1361-3.
96. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: Morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 2003; 12(6):599-605.
97. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opin Organ transplant 2000; 5:210-216.
98. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3(10):611-23.
99. Kazory A, Ducloux D. Renal transplantation and polyomavirus infection: Recent clinical facts and controversies. Transpl Infect Dis 2003; 5(2):65-71.
100. Mylonakis E, Goes N, Rubin RH et al. BK virus in solid organ transplant recipients: An emerging syndrome. Transplantation 2001; 72(10):1587-92.
101. Fishman JA. BK virus nephropathy-polyomavirus adding insult to injury. N Engl J Med 2002; 347(7):527-30.
102. Pahari A, Rees L. BK virus-associated renal problems-clinical implications. Pediatr Nephrol 2003; 18(8):743-8.
103. Reploeg MD, Storch GA, Clifford DB. BK virus: A clinical review. Clin Infect Dis 2001; 33(2):191-202.
104. Li RM, Mannon RB, Kleiner D et al. BK virus and SV40 coinfection in polyomavirus nephropathy. Transplantation 2002; 74(11):1497-504.
105. Ding R, Medeiros M, Dadhania D et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 2002; 74(7):987-94.
106. Randhawa P, Zygmunt D, Shapiro R et al. Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int 2003; 64(2):743-7.
107. Randhawa PS, Vats A, Zygmunt D et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation 2002; 74(4):485-8.
108. Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002; 73(7):1090-4.
109. Leung AY, Chan M, Tang SC et al. Real-time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients. J Virol Methods 2002; 103(l):51-6.
110. Bergallo M, Merlino C, Bollero C et al. Human polyoma virus BK DNA detection by nested PCR in renal transplant recipients. New Microbiol 2002; 25(3):331-4.
111. CF, Randhawa P. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Am J Kidney Dis 2001; 38(2):354-65.
112. Boldorini R, Zorini EO, Fortunato M et al. Molecular characterization and sequence analysis of polyomavirus BKV-strain in a renal-allograft recipient. Hum Pathol 2001; 32(6):656-9.
113. Fogazzi GB, Cantu M, Saglimbeni L. 'Decoy cells' in the urine due to polyomavirus BK infection: Easily seen by phase-contrast microscopy. Nephrol Dial Transplant 2001; 16(7):1496-8.
114. Randhawa P, Baksh F, Aoki N et al. JC virus infection in allograft kidneys: Analysis by polymerase chain reaction and immunohistochemistry. Transplantation 2001; 71(9):1300-3.
115. Limaye AP, Jerome KR, Kuhr CS et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis 2001; 183(11):1669-72.
116. Chen CH, Wen MC, Wang M et al. A regulatory region rearranged BK virus is associated with t tubulointerstitial nephritis in a rejected renal allograft. J Med Virol 2001; 64(1):82-8.
117. Nickeleit V, Hirsch HH, Zeiler M et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15(3):324-32.
118. Nickleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342:1309-15.
119. Jin L. Molecular methods for identification and genotyping of BK virus. Methods Mol Biol 2001; 165:33-48.
120. Andrews CA, Shah KV, Daniel RW et al. A serologic investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 1988; 158:176-181.
121. Coleman D, Mackenzie S, Gardner S et al. Human polyomavirus (BK) infection and ureteral stenosis in renal allograft recipients. J Clin Pathol 1978; 31:338-347.
122. Constantinescu A, Ahsan N, Lim JW. Polyomavirus allograft nephropathy - parenchymal and extra-parenchymal manifestations. GRAFT 2002; 5:S98-S103.
123. Agha IA, Brennan DC. BK virus and current immunosuppressive therapy. Graft 2002; 5:S65-S72.
124. Petrogiannis-Haliotis T, Sakoulas G, Kirby J et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001; 345:1250-5.
125. Bedi A, Miller CB, Hanson JL et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13(5):1103-9.
126. Nevo S, Swan V, Enger C et al. Acute bleeding after bone marrow transplantation (BMT) incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood 1998; 91(4):1469-77.
127. Seber A, Shu XO, Defor T et al. Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplant 1999; 23(1):35-40.
128. Kondo M, Kojima S, Kato K et al. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 1998; 22(10):995-8.
129. Arthur RR, Shah KV, Baust SJ et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315:230-234.
130. Chapman C, Flower AJ, Dunant ST. The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis. Bone Marrow Transplant 1991; 7:481-482.
131. Cottler-Fox M, Lynch M, Deeg JH et al. Human polyomavirus: Lack of relationship of viruria to prolonged or severe hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant 1989; 4:279-282.
132. Johnson R. Progressive multifocal leukoencephalopathy. In: Johnson R, ed. Viral infections of the nervous system. New York: Raven Press, 1982:255-263.
133. Richardson EP. Progressive multifocal leukoencephalopathy 30 years later. N Engl J Med 1988; 318:315-316.
134. Walker DL. Progressive multifocal leukoencephalopathy. Demyelinating diseases. In: Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC, eds. Handbook of Clinical Neurology. Amsterdam: Elsevier Biomedical Press, 1985:4(7):503-524.
135. Berger JR, Kaszovita B, Donovan Post J et al. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 1987; 107:78-87.
136. Berger JR, Levy RM. The neurologic complications of human immunodeficiency virus infections. Med Clin North Am 1993; 77:1-23.
137. Major EO, Amemiya K, Tornatore CS et al. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992; 5:49-73.
138. White IIIrd FA , Ishaq M, Stoner GL et al. JC virus DNA is pre sent in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 1992; 66:5726-5734.
139. von Giesen HJ, Neuen-Jacob E, Dorries K et al. Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. J Neurol Sci 1997; 147(1):63-72.
140. Berger JR, Major EO. Progressive multifocal leukoencephalopathy. Semin Neurol 1999; 19(2):193-200.
141. Gibson PI, Knowles WA, Hand JF et al. Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 1993; 39:278-281.
142. Grinnell B, Padgett B, Walker D. Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy. J Infect Dis 1983; 147:669-675.
143. Knowles WA, Pipkin P, Andrews N et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71(1):115-23.
144. Shah KV, Daniel RW, Strickler HD et al. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis 1997; 176:1618-1621.
145. David H, Mendoza S, konishi T et al. Simian virus 40 is present in human lymphomas and normal blood. Cancer let 2001; 162:57-64.
146. Martini F, Iaccheri L, Lazzarin L et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996; 56(20):4820-5.
147. Li RM, Branton MH, Tanawattanacharoen S et al. Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002; 13(9):2320-30.
148. Butel JS, Jafar S, Wong C et al. Evidence of SV40 infections in hospitalized children. Hum Pathol 1999; 30(12):1496-502.
149. Shah K, Nathanson N. Human exposure to SV40: Review and comment. Am J Epidemiol 1976; 103:1-12.
150. Lee W, Langhoff E. polyomavirus and human cancer. Graft 2002; 5:S73-S81.
151. Mayall F, Barratt K, Shanks J. The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols. J Clin Pathol 2003; 56(10):728-30.
152. Reiss K, Khalili K. Viruses and cancer: Lessons from the human polyomavirus, JCV. Oncogene 2003; 22(42):6517-23.
153. Tognon M, Corallini A, Martini F et al. Oncogenic transformation by BK virus and association with human tumors. Oncogene 2003; 22(33):5192-200.
154. Khalili K, Del Valle L, Otte J et al. Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene 2003; 22(33):5181-91.
155. Carbone M, Pass HI, Miele L et al. New developments about the association of SV40 with human mesothelioma. Oncogene 2003; 22(33):5173-80.
156. Vilchez RA, Butel JS. SV40 in human brain cancers and nonHodgkin's lymphoma. Oncogene 2003; 22(33):5l64-72.
157. MacKenzie J, Wilson KS, Perry J et al. Association between simian virus 40 DNA and lymphoma in the United kingdom. J Natl Cancer Inst 2003; 95(13):1001-3.
158. Vilchez RA, Kozinetz CA, Arrington AS et al. Simian virus 40 in human cancers. Am J Med 2003; 114(8):675-84.
159. Carbone M, Bocchetta M, Cristaudo A et al. SV40 and human brain tumors. Int J Cancer 2003; 106(1):140-2, author reply 143-5.
160. Rinaldo CH, Myhre MR, Alstad H et al. Human polyomavirus BK (BKV) transiently transforms and persistently infects cultured osteosarcoma cells. Virus Res 2003; 93(2):181-7.
161. Rinaldo CH, Myhre MR, Alstad H et al. Human polyomavirus BK (BKV) transiently transforms and persistently infects cultured osteosarcoma cells. Virus Res 2003; 93(2):181-7.
162. Vilchez RA, Kozinetz CA, Butel JS. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol 2003; 4(3):188-91.
163. Gardner SD. Prevalence in England of antibody to human polyomavirus BK. Br Med J 1973; 1:77-78.
164. Shah K, Daniel R, Warszawski R. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128:784-787.
165. Drachenberg CB, Beskow CO, Cangro CB et al. Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology. Hum Pathol 1999; 30:970-977.
166. Purighalla R, Shapiro R, McCauley J et al. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26:671-73.
167. Ginevri F, Pastorino N, De Santis R et al. Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 2003; 42(4):821-5.
168. Ramos E, Drachenberg CB, Papadimitriou JC et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13(8):2145-51.
169. Trofe J, Cavallo T, First MR et al. Polyomavirus in kidney and kidney-pancreas transplantation: A defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc 2002; 34(5):1788-9.
170. Hirsch HH, Mohaupt M, Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J Infect Dis 2001; 184:1494-6.
171. Poduval RD, Meehan SM, Woodle ES et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation 2002; 73:1166-69.
172. Fishman JA. BK nephropathy: What is the role of antiviral therapy? Am J Transplant 2003; 3(2):99-100.
173. Scantlebury V, Shapiro R, Randhawa P et al. Cidofovir: A method of treatment for BK virus-associated transplant nephropathy. Graft 2002; 5:S82-S87.
174. Kadambi PV, Josephson MA, Williams J et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant 2003; 3(2):186-91.
175. Vats A, Shapiro R, Singh Randhawa P et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75(1):105-12.
176. Bjorang O, Tveitan H, Midtvedt K et al. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant 2002; 17(11):2023-5.
177. Held TK, Biel SS, Nitsche A et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant 2000; 26:347-50.
178. Cibrik DM, O'Toole JF, Norman SP et al. IVIG for the treatment of BK nephropathy. Am J Transplantation 2003; 3:370,(abstract).
179. Cheesman SH, Black PH, Rubin RH et al. Interferon and BK Papovavirus - clinical and laboratory studies. J Infect Dis 1980; 141:157-61.
180. th International conference on New Trends in Clinical and experimental immunosuppression, 2002, (Abstract).
181. Poduval RD, Kadambi PV, Javaid B et al. Leflunomide - a potential new therapeutic agent for BK nephropathy. Am J Transplantation 2003; 3:189,(abstract).
182. Foster PF, Wright F, McLean D et al. Leflunomide administration as an adjunct in treatment of BK-polyoma viral disease in kidney allografts. Am J Transplantation 2003; 3:421,(abstract).
183. Feiden W, Bise K, Steude U et al. The stereotactic biopsy diagnosis of focal intracerebral lesions in AIDS patients. Acta Neurol Scand 1993; 87:228-233.
184. Hair LS, Nuovo G, Powers JM et al. Progressive multifocal leukoencephalopathy in patients with human immunodeficiency virus. Hum Pathol 1992; 23:663-667.
185. Koralnik IJ, Du Pasquier RA, Kuroda MJ et al. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope. J Immunol 2002; 168:499-504.